Abstract:Background: The ability to predict Alzheimers disease (AD) before diagnosis is a topic of intense research. Early diagnosis would aid in improving treatment and intervention options, however, there are no current methods that can accurately predict AD years in advance. This study examines a novel machine learning approach that integrates the combined effects of vascular (white matter hyperintensities, WMHs), and structural brain changes (gray matter, GM) with clinical factors (cognitive status) to predict post-mortem neuropathological outcomes. Methods: Healthy older adults, participants with mild cognitive impairment, and AD from the Alzheimer's Disease Neuroimaging Initiative dataset with both post-mortem neuropathology data and antemortem MRI and clinical data were included. Longitudinal data were analyzed across three intervals before death (post-mortem data): 0-4 years, 4-8 years, and 8-14 years. Additionally, cross-sectional data at the last visit or interval (within four years, 0-4 years) before death were also examined. Machine learning models including gradient boosting, bagging, support vector regression, and linear regression were implemented. These models were applied towards feature selection of the top seven MRI, clinical, and demographic data to identify the best performing set of variables that could predict postmortem neuropathology outcomes (i.e., neurofibrillary tangles, neuritic plaques, diffuse plaques, senile/amyloid plaques, and amyloid angiopathy). Results: A total of 94 participants (55-90 years of age) were included in the study. At last visit, the best-performing model included total and temporal lobe WMHs and achieved r=0.87(RMSE=0.62) during cross-validation for neuritic plaques. For longitudinal assessments across different intervals, the best-performing model included regional GM (i.e., hippocampus, amygdala, caudate) and frontal lobe WMH and achieved r=0.93(RMSE=0.59) during cross-validation for neurofibrillary tangles. For MRI and clinical predictors and clinical-only predictors, t-tests demonstrated significant differences at all intervals before death (t[-13.60-7.90], p-values<0.001). Overall, post-mortem neuropathology outcome were predicted up to 14 years before death with high accuracies (~90%). Conclusions: Prediction accuracy was higher for post-mortem neuropathology outcomes that included MRI (WMHs, GM) and clinical features compared to clinical-only features. These findings highlight that MRI features are critical to successfully predict AD-related pathology years in advance which will improve participant selection for clinical trials, treatments, and intervention options.

Machine Learning-Driven Prediction of Brain Age for Alzheimer's Risk: APOE4 Genotype and Gender Effects

Predicting Alzheimer's Disease with Interpretable Machine Learning.

Using Machine Learning and Electronic Health Record (EHR) Data for the Early Prediction of Alzheimer's Disease and Related Dementias.

Early Prediction of Alzheimer's Disease and Related Dementias Using Real-World Electronic Health Records.

Predicting Alzheimer's disease from cognitive footprints in mid and late life: How much can register data and machine learning help?

Predicting Alzheimer’s Disease from Cognitive Footprints in Mid and Late Life: How Much Can Register Data and Machine Learning Help?

Comparison of Machine Learning Models for Brain Age Prediction Using Six Imaging Modalities on Middle-Aged and Older Adults

Alzheimer’s disease risk prediction using automated machine learning

Machine Learning Predicts Conversion from Normal Aging to Mild Cognitive Impairment Using Medical History, APOE Genotype, and Neuropsychological Assessment

Machine learning for the prediction of cognitive impairment in older adults

Predicting Mild Cognitive Impairment in Older Adults: A Machine Learning Analysis of the Alzheimer's Disease Neuroimaging Initiative.

Predicting Brain Age Gap with Radiomics and AutoML: A Promising Approach for Age-Related Brain Degeneration Biomarkers

Exploring the power of MRI and clinical measures in predicting Alzheimers disease neuropathology

Machine Learning Approach for Improved Longitudinal Prediction of Progression from Mild Cognitive Impairment to Alzheimer’s Disease

An explainable machine learning based prediction model for Alzheimer's disease in China longitudinal aging study

Investigating Predictors of Progression from Mild Cognitive Impairment to Alzheimer’s Disease Based on Different Time Intervals

Data-driven discovery of probable Alzheimer's disease and related dementia subphenotypes using electronic health records

Development of a Novel Dementia Risk Prediction Model in the General Population: A Large, Longitudinal, Population-Based Machine-Learning Study

Application of Machine Learning to Predict the Risk of Alzheimer's Disease: An Accurate and Practical Solution for Early Diagnostics

Predicting early Alzheimer's with blood biomarkers and clinical features

Predicting the apolipoprotein E ε4 allele carrier status based on gray matter volumes and cognitive function